Mariana Oliveira Nunes
Cancer Drug Resistance
Technician
I am currently a PhD student in Differentiation and Cancer Group and in the Doutoral Progrma in Pathology and Molecular Genetic in the Institute of Biomedical Sciences Abel Salazar of the University of Porto.
In 2019, I obtained a master’s degree in Oncology by Institute of Biomedical Sciences Abel Salazar from University of Porto. My Master´s Dissertation “First line drug testing in ovarian cancer cell lines manipulated for Mesothelin expression", was performed under scientific supervision of Doctor Sara Ricardo and Doctor Leonor David in Differentiation and Cancer Group at i3S.
In 2016, I completed by Bachelor´s degree in Biology at the University of Aveiro with an internship in Genomics Unit at Biocant (University of Coimbra).
Selected Publications
Nunes M., Abreu M.H., Bartosch C., Ricardo S.
Recycling the purpose of old drugs to treat ovarian cancer. International Journal of Molecular Sciences21(20):1-24, 2020. [Journal: Review] [CI: 22] [IF: 5,9]
DOI: 10.3390/ijms21207768 SCOPUS: 85093658021
Nunes M., Coelho R., Pinto C., Resende A., Bousbaa H., Almeida G.M., Ricardo S.
Generation of Two Paclitaxel-Resistant High-Grade Serous Carcinoma Cell Lines With Increased Expression of P-Glycoprotein. Frontiers in Oncology11:, 2021. [Journal: Article] [CI: 22] [IF: 5,7]
DOI: 10.3389/fonc.2021.752127 SCOPUS: 85118608070
Nunes M., Pacheco F., Coelho R., Leitão D., Ricardo S., David L.
Mesothelin Expression Is Not Associated with the Presence of Cancer Stem Cell Markers SOX2 and ALDH1 in Ovarian Cancer. International Journal of Molecular Sciences23(3):, 2022. [Journal: Article] [CI: 2] [IF: 5,6]
DOI: 10.3390/ijms23031016 SCOPUS: 85122857215
Coelho R., Ricardo S., Amaral A.L., Huang Y.L., Nunes M., Neves J.P., Mendes N., López M.N., Bartosch C., Ferreira V., Portugal R., Lopes J.M., Almeida R., Heinzelmann-Schwarz V., Jacob F., David L.
Regulation of invasion and peritoneal dissemination of ovarian cancer by mesothelin manipulation. Oncogenesis9(6):, 2020. [Journal: Article] [CI: 48] [IF: 7,5]
DOI: 10.1038/s41389-020-00246-2 SCOPUS: 85087314253
Félix C., Libório S., Nunes M., Félix R., Duarte A.S., Alves A., Esteves A.C.
Lasiodiplodia theobromae as a producer of biotechnologically relevant enzymes. International Journal of Molecular Sciences19(2):, 2018. [Journal: Article] [CI: 22] [IF: 4,2]
DOI: 10.3390/ijms19020029 SCOPUS: 85041037451
Pinto C., Custódio V., Nunes M., Songy A., Rabenoelina F., Courteaux B., Clément C., Gomes A.C., Fontaine F.
Understand the potential role of aureobasidium pullulans, a resident microorganism from grapevine, to prevent the infection caused by Diplodia seriata. Frontiers in Microbiology9(DEC):, 2018. [Journal: Article] [CI: 43] [IF: 4,3]
DOI: 10.3389/fmicb.2018.03047 SCOPUS: 85058299482
Nunes M., Coelho R., Pinto C., Resende A., Bousbaa H., Almeida G.M., Ricardo S.
Corrigendum: Generation of Two Paclitaxel-Resistant High-Grade Serous Carcinoma Cell Lines With Increased Expression of P-Glycoprotein(Front. Oncol., (2021), 11, (752127), 10.3389/fonc.2021.752127). Frontiers in Oncology12:, 2022. [Journal: Erratum] [IF: 4,7]
DOI: 10.3389/fonc.2022.853608 SCOPUS: 85124947543
Magalhães A.C., Ricardo S., Moreira A.C., Nunes M., Tavares M., Pinto R.J., Gomes M.S., Pereira L.
InfectionCMA: A Cell MicroArray Approach for Efficient Biomarker Screening in In Vitro Infection Assays. Pathogens11(3):, 2022. [Journal: Article] [CI: 4] [IF: 3,7]
DOI: 10.3390/pathogens11030313 SCOPUS: 85126676736
Duarte D., Nunes M., Ricardo S., Vale N.
Combination of Antimalarial and CNS Drugs with Antineoplastic Agents in MCF-7 Breast and HT-29 Colon Cancer Cells: Biosafety Evaluation and Mechanism of Action. Biomolecules12(10):, 2022. [Journal: Article] [CI: 31] [IF: 5,5]
DOI: 10.3390/biom12101490 SCOPUS: 85140479665
Nunes M., Duarte D., Vale N., Ricardo S.
Pitavastatin and Ivermectin Enhance the Efficacy of Paclitaxel in Chemoresistant High-Grade Serous Carcinoma. Cancers14(18):, 2022. [Journal: Article] [CI: 14] [IF: 5,2]
DOI: 10.3390/cancers14184357 SCOPUS: 85138730639
Recycling the purpose of old drugs to treat ovarian cancer. International Journal of Molecular Sciences21(20):1-24, 2020. [Journal: Review] [CI: 22] [IF: 5,9]
DOI: 10.3390/ijms21207768 SCOPUS: 85093658021
Nunes M., Coelho R., Pinto C., Resende A., Bousbaa H., Almeida G.M., Ricardo S.
Generation of Two Paclitaxel-Resistant High-Grade Serous Carcinoma Cell Lines With Increased Expression of P-Glycoprotein. Frontiers in Oncology11:, 2021. [Journal: Article] [CI: 22] [IF: 5,7]
DOI: 10.3389/fonc.2021.752127 SCOPUS: 85118608070
Nunes M., Pacheco F., Coelho R., Leitão D., Ricardo S., David L.
Mesothelin Expression Is Not Associated with the Presence of Cancer Stem Cell Markers SOX2 and ALDH1 in Ovarian Cancer. International Journal of Molecular Sciences23(3):, 2022. [Journal: Article] [CI: 2] [IF: 5,6]
DOI: 10.3390/ijms23031016 SCOPUS: 85122857215
Coelho R., Ricardo S., Amaral A.L., Huang Y.L., Nunes M., Neves J.P., Mendes N., López M.N., Bartosch C., Ferreira V., Portugal R., Lopes J.M., Almeida R., Heinzelmann-Schwarz V., Jacob F., David L.
Regulation of invasion and peritoneal dissemination of ovarian cancer by mesothelin manipulation. Oncogenesis9(6):, 2020. [Journal: Article] [CI: 48] [IF: 7,5]
DOI: 10.1038/s41389-020-00246-2 SCOPUS: 85087314253
Félix C., Libório S., Nunes M., Félix R., Duarte A.S., Alves A., Esteves A.C.
Lasiodiplodia theobromae as a producer of biotechnologically relevant enzymes. International Journal of Molecular Sciences19(2):, 2018. [Journal: Article] [CI: 22] [IF: 4,2]
DOI: 10.3390/ijms19020029 SCOPUS: 85041037451
Pinto C., Custódio V., Nunes M., Songy A., Rabenoelina F., Courteaux B., Clément C., Gomes A.C., Fontaine F.
Understand the potential role of aureobasidium pullulans, a resident microorganism from grapevine, to prevent the infection caused by Diplodia seriata. Frontiers in Microbiology9(DEC):, 2018. [Journal: Article] [CI: 43] [IF: 4,3]
DOI: 10.3389/fmicb.2018.03047 SCOPUS: 85058299482
Nunes M., Coelho R., Pinto C., Resende A., Bousbaa H., Almeida G.M., Ricardo S.
Corrigendum: Generation of Two Paclitaxel-Resistant High-Grade Serous Carcinoma Cell Lines With Increased Expression of P-Glycoprotein(Front. Oncol., (2021), 11, (752127), 10.3389/fonc.2021.752127). Frontiers in Oncology12:, 2022. [Journal: Erratum] [IF: 4,7]
DOI: 10.3389/fonc.2022.853608 SCOPUS: 85124947543
Magalhães A.C., Ricardo S., Moreira A.C., Nunes M., Tavares M., Pinto R.J., Gomes M.S., Pereira L.
InfectionCMA: A Cell MicroArray Approach for Efficient Biomarker Screening in In Vitro Infection Assays. Pathogens11(3):, 2022. [Journal: Article] [CI: 4] [IF: 3,7]
DOI: 10.3390/pathogens11030313 SCOPUS: 85126676736
Duarte D., Nunes M., Ricardo S., Vale N.
Combination of Antimalarial and CNS Drugs with Antineoplastic Agents in MCF-7 Breast and HT-29 Colon Cancer Cells: Biosafety Evaluation and Mechanism of Action. Biomolecules12(10):, 2022. [Journal: Article] [CI: 31] [IF: 5,5]
DOI: 10.3390/biom12101490 SCOPUS: 85140479665
Nunes M., Duarte D., Vale N., Ricardo S.
Pitavastatin and Ivermectin Enhance the Efficacy of Paclitaxel in Chemoresistant High-Grade Serous Carcinoma. Cancers14(18):, 2022. [Journal: Article] [CI: 14] [IF: 5,2]
DOI: 10.3390/cancers14184357 SCOPUS: 85138730639
